Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development.

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Abstract Text:

Sumithra Urs,Anne Harrington,Lucy Liaw,Deena Small,

Mouse strains expressing the site-specific Cre recombinase facilitate conditional ablation or activation of genomic sequences when one or several exons of a gene of interest are flanked by loxP sites. Recently, several strains targeting Cre expression to adipocytes have been developed using promoter sequences from the aP2 (Fatty Acid Binding Protein 4, FABP4) gene for adipose tissue-specific gene expression studies. aP2/FABP4 is predominantly expressed in adipose tissue, and while this promoter provides adipocyte-restricted expression postnatally, its expression throughout embryonic development had not been previously characterized. In this report, we demonstrate that the aP2-Cre transgene is expressed and consistently localized within the embryo from mid-gestation stage 9.5 dpc. By 15.5 dpc, beta-gal activity was detected primarily in the brown adipose tissue, trigeminal ganglia, dorsal root ganglia, cartilage primordia and vertebrae. Immunofluorescence staining for Cre recombinase and FABP4 protein showed a corresponding staining pattern similar to that of beta-gal, confirming that Cre recombinase was produced in the transgenic line at late stages of development, and overlapped with endogenous aP2/FABP4 production. Further, fat-specific oil red O staining of tissue sections validated the presence of lipids in the stained tissues indicating that adipocytes and/or adipocyte-like cells were indeed present in these tissues. This is the first report to our knowledge to describe and confirm aP2/FABP4 promoter expression in this transgenic line during development in the mouse embryo and indicates that aP2/FABP4 expression occurs not only in mature adipocytes, but has a wider embryonic expression pattern than previously appreciated.

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Publishing Authors By Initials

S Urs,A Harrington,L Liaw,D Small,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Transgenic research

VOLUME: 15

Page Numbers: 647-53

Journal Abbreviation:

ISSN: 0962-8819

DAY: 2

MONTH: 09

YEAR: 2006

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9209120

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development.

AFFILIATION: Center for Molecular Medicine, Maine Medical Center Research Institute, 81 Research Drive, Scarborough, Maine 04074, USA.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Transgenic Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development Related Publications

• 281.
• Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.
• Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
• An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.
• Blank augmentation protocol for improving the robustness of multivariate calibrations.
• CA3 NMDA receptors are required for experience-dependent shifts in hippocampal activity.
• Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
• Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells.
• Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F.
• Hearing lips and seeing voices: how cortical areas supporting speech production mediate audiovisual speech perception.
• Imaging the earliest stages of Alzheimer's disease.
• Imaging-guided microarray: isolating molecular profiles that dissociate Alzheimer's disease from normal aging.
• Jagged-1hi or Delta-1hi thymic stromal cell populations can trigger acquisition of Thy-1 and loss of B220.
• Longitudinal mapping of mouse cerebral blood volume with MRI.
• Molecular evolution of the Li/li chemical defence polymorphism in white clover (Trifolium repens L.).
• Photoacoustic characterization of protein dynamics following CO photodetachment from fully reduced bovine cytochrome c oxidase.
• Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors.
• Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.
• Psychosocial functioning of adults who experienced substance use disorders as adolescents.
• Quantitative determination of ethanol in heated plumes by passive Fourier transform infrared remote sensing measurements.
• Repetition suppression for spoken sentences and the effect of task demands.
• Screening for depressive symptoms in patients with unresectable lung cancer.
• Selective expression of an aP2/Fatty Acid Binding Protein 4-Cre transgene in non-adipogenic tissues during embryonic development.
• Spectral simulation methodology for calibration transfer of near-infrared spectra.
• Speech-associated gestures, Broca's area, and the human mirror system.
• Task-dependent changes in brain activation following therapy for nonfluent aphasia: discussion of two individual cases.
• The mind of expert motor performance is cool and focused.
• Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease.
• Trying to detect taste in a tasteless solution: modulation of early gustatory cortex by attention to taste.
• Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial.